CARMEN SHERRY: Open Payments
NPI 1215623327 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 25 payments from 13 companies in 2025. Trend: 2023 $89 · 2024 $641 · 2025 $588
Food & beverage: $559Education: $29
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $93 |
| AKEBIA THERAPEUTICS INC | 4 | $89 |
| Novo Nordisk Inc | 3 | $63 |
| Lilly USA, LLC | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| Vifor Pharma, Inc. | 1 | $30 |
| OPKO Pharmaceuticals, LLC | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Fresenius USA Marketing, Inc. | 1 | $24 |
Products named: Kerendia, Vafseo, JYNARQUE, JARDIANCE, Wegovy, ACTHAR, Veltassa, RAYALDEE.
Industry payments across PA — which companies pay providers there.
